000 01636cam  2200397zi 4500
0019.941542
003CaOODSP
00520240823104401
006m     o  d f      
007cr cn ||||||||
008240807e202408  onc     o    f000 0 eng d
020 |a9780660730448
040 |aCaOODSP|beng|erda|cCaOODSP
043 |an-cn---
0861 |aH164-305/2024E-PDF
24500|aGuidance document : |bcertificates of supplementary protection.
24630|aCertificates of supplementary protection
24637|aCSP guidance document
264 1|aOttawa, ON : |bHealth Canada = Santé Canada, |cAugust 2024.
264 4|c©2024
300 |a1 online resource (28 pages)
336 |atext|btxt|2rdacontent
337 |acomputer|bc|2rdamedia
338 |aonline resource|bcr|2rdacarrier
500 |aIssued also in French under title: Ligne directrice : certificats de protection supplémentaire.
500 |a"Effective date: 2024/08/19."
500 |a"Pub.: 240421."
650 0|aPatent medicines|zCanada.
650 0|aPatent extensions|zCanada.
650 0|aPharmaceutical policy|zCanada.
7101 |aCanada. |bHealth Canada, |eissuing body.
77508|tLigne directrice : |w(CaOODSP)9.941541
795 |tGuidance document : |w(CaOODSP)9.931029
85640|qPDF|s518 KB|uhttps://publications.gc.ca/collections/collection_2024/sc-hc/H164-305-2024-eng.pdf
8564 |qHTML|sN/A|uhttps://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/register-certificates/certificate-supplementary-protection-regulations.html